We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GENFIT : Publication du rapport de performance extra-financière 2024 (exercice 2023) Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 25 avril 2024 – GENFIT (Nasdaq...
GENFIT : Assemblée Générale Mixte du 22 mai 2024 — modalités de mise à disposition des documents préparatoires Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 15...
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 15, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving...
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 5, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving...
GENFIT : Résultats financiers annuels 2023 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 77,8 millions d’euros au 31 décembre 2023Chiffre...
Cash and cash equivalents totaled €77.8 million as of December 31, 2023Revenues amounted to €28.6 million as of December 31, 2023 including a milestone payment of €13.3 million Upcoming FDA PDUFA...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 1.58227848101 | 3.16 | 3.27 | 3.13 | 53696 | 3.19942212 | DE |
4 | -0.13 | -3.89221556886 | 3.34 | 3.47 | 3.025 | 98909 | 3.23851095 | DE |
12 | -0.34 | -9.57746478873 | 3.55 | 3.78 | 3.025 | 118635 | 3.33901857 | DE |
26 | 0.29 | 9.93150684932 | 2.92 | 3.87 | 2.88 | 202700 | 3.36746217 | DE |
52 | -0.18 | -5.30973451327 | 3.39 | 4.92 | 2.84 | 227353 | 3.45061377 | DE |
156 | -0.4 | -11.08033241 | 3.61 | 4.95 | 2.746 | 179219 | 3.65857337 | DE |
260 | -19.45 | -85.8340688438 | 22.66 | 22.96 | 2.746 | 303511 | 6.87713578 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions